GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocCheck AG (XTER:AJ91) » Definitions » Shares Outstanding (EOP)

DocCheck AG (XTER:AJ91) Shares Outstanding (EOP) : 5.07 Mil (As of Jun. 2023)


View and export this data going back to 2000. Start your Free Trial

What is DocCheck AG Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. DocCheck AG's shares outstanding for the quarter that ended in Jun. 2023 was 5.07 Mil.

DocCheck AG's quarterly shares outstanding increased from Dec. 2022 (5.03 Mil) to Jun. 2023 (5.07 Mil). It means DocCheck AG issued new shares from Dec. 2022 to Jun. 2023 .

DocCheck AG's annual shares outstanding stayed the same from Dec. 2021 (5.03 Mil) to Dec. 2022 (5.03 Mil).


DocCheck AG Shares Outstanding (EOP) Historical Data

The historical data trend for DocCheck AG's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DocCheck AG Shares Outstanding (EOP) Chart

DocCheck AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.99 4.99 5.03 5.03 5.03

DocCheck AG Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.03 5.03 5.03 5.03 5.07

Competitive Comparison of DocCheck AG's Shares Outstanding (EOP)

For the Health Information Services subindustry, DocCheck AG's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DocCheck AG's Shares Outstanding (EOP) Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DocCheck AG's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where DocCheck AG's Shares Outstanding (EOP) falls into.



DocCheck AG Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


DocCheck AG  (XTER:AJ91) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


DocCheck AG Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of DocCheck AG's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


DocCheck AG (XTER:AJ91) Business Description

Traded in Other Exchanges
Address
Doccheck AG, Vogelsanger Strac E 66, Koln, DEU, 50823
DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.
Executives
Dr. Frank Antwerpes Board of Directors

DocCheck AG (XTER:AJ91) Headlines

No Headlines